Gronwald, J., Robidoux, A., Kim-Sing, C., Tung, N., Lynch, H. T., Foulkes, W. D., . . . Narod, S. A. (2014). Duration of Tamoxifen Use and the Risk of Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Chicago-tyylinen lähdeviittausGronwald, Jacek, et al. Duration of Tamoxifen Use and the Risk of Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. 2014.
MLA-viiteGronwald, Jacek, et al. Duration of Tamoxifen Use and the Risk of Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.